Home LiteratureArticle Details
PMID: 6308049 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Killing of intracellular Leishmania donovani by human mononuclear phagocytes. Evidence for oxygen-dependent and -independent leishmanicidal activity.

The Journal of clinical investigation ·Vol. 72 ·No. 1 ·1983-07-00 ·Pages 32-44

Murray HW, Cartelli DM

Abstract

Human peripheral blood monocytes were cultivated for 1-30 d before assay for H2O2 release or challenge with Leishmania donovani promastigotes (LDP) or amastigotes (LDA). 1-d cells readily generated H2O2 in response to both phorbol myristate acetate triggering (1,013 +/- 58 nmol/mg protein . 90 min) and LDP ingestion, and killed 50% of LDP within 6 h, and 90% by 24 h. In contrast, the same cells released little H2O2 during LDA ingestion, killed no LDA at 6 h and less than 30% by 24 h, and supported intracellular LDA replication. Monocyte-derived macrophages (cells first cultivated for greater than or equal to 7 d) generated less than 125 nmol H2O2/mg . 90 min after phorbol myristate acetate triggering, killed neither LDP nor LDA, and permitted both forms to replicate. The addition of mitogen- or antigen-stimulated lymphokines, however, prevented the decline in monocyte oxidative capacity, enhanced macrophage H2O2 release by more than sixfold, and, in parallel, induced 1-d monocytes to kill LDA and cultivated macrophages to display both promastigocidal and amastigocidal activity. In comparison to 1-d monocytes and lymphokine-activated macrophages from normal donors, the same cells from patients with chronic granulomatous disease (CGD) or normal cells whose oxidative activity had been impaired by catalase pretreatment or glucose deprivation exerted considerably less or no antileishmanial activity during the early (6-24 h) postphagocytic period. By 48 h after infection, however, 1-d CGD monocytes and oxidatively impaired normal cells killed 40 and greater than 80% of LDP, respectively. Although a longer period of lymphokine stimulation was required and the resulting antileishmanial effects were not as rapid as with normal cells, activated CGD monocytes and macrophages also eventually achieved promastigocidal and amastigostatic activity. These results indicate that human mononuclear phagocytes utilize both oxygen-dependent and -independent mechanisms to achieve activity against ingested Leishmania, and also demonstrate (a) the differential susceptibilities of the two forms of L. donovani to intracellular killing, (b) the key role of oxygen intermediates in effective mononuclear phagocyte antimicrobial activity, (c) the capacity of lymphocyte products to enhance oxygen-dependent as well as -independent pathways, and (d) the vulnerability of the monocyte-derived macrophage to Leishmania infection in the absence of lymphokine stimulation.

MeSH Terms
Granulomatous Disease, Chronic/blood Humans Hydrogen Peroxide/metabolism Leishmania/growth & development,physiology Lymphokines/pharmacology Macrophages/physiology Monocytes/physiology Oxygen/pharmacology Phagocytes/physiology Superoxides/metabolism
Chemicals
Lymphokines Superoxides Hydrogen Peroxide Oxygen
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Murray H W
Cartelli D M
References (39)
39 references, click to expand
  1. Inhibition of multiplication of Toxoplasma gondii by human monocytes exposed to T-lymphocyte products.
    J Exp Med. 1975 Feb 1;141(2):483-96 PMID: 1089746
  2. The fungicidal mechanisms of human monocytes. I. Evidence for myeloperoxidase-linked and myeloperoxidase-independent candidacidal mechanisms.
    J Clin Invest. 1975 Feb;55(2):338-46 PMID: 123929
  3. The biochemical basis of nitroblue tetrazolium reduction in normal human and chronic granulomatous disease polymorphonuclear leukocytes.
    Blood. 1976 Aug;48(2):309-13 PMID: 949553
  4. Induction of resistance to Toxoplasma gondii in human macrophages by soluble lymphocyte products.
    J Immunol. 1976 Aug;117(2):381-7 PMID: 950460
  5. The separation, long-term cultivation, and maturation of the human monocyte.
    J Exp Med. 1977 Dec 1;146(6):1613-26 PMID: 925613
  6. Oxygen-dependent microbial killing by phagocytes (second of two parts).
    N Engl J Med. 1978 Mar 30;298(13):721-5 PMID: 203852
  7. Extracellular cytolysis by activated macrophages and granulocytes. II. Hydrogen peroxide as a mediator of cytotoxicity.
    J Exp Med. 1979 Jan 1;149(1):100-13 PMID: 216763
  8. Bactericidal activity of a superoxide anion-generating system. A model for the polymorphonuclear leukocyte.
    J Exp Med. 1979 Jan 1;149(1):27-39 PMID: 216766
  9. Activation of macrophages in vivo and in vitro. Correlation between hydrogen peroxide release and killing of Trypanosoma cruzi.
    J Exp Med. 1979 May 1;149(5):1056-68 PMID: 376774
  10. Alterations of the immune response associated with chronic experimental leishmaniasis.
    Infect Immun. 1979 Jul;25(1):16-22 PMID: 157979
  11. Multiplication of Leishmania in human macrophages in vitro.
    Infect Immun. 1979 Oct;26(1):375-9 PMID: 500212
  12. Macrophage oxygen-dependent antimicrobial activity. I. Susceptibility of Toxoplasma gondii to oxygen intermediates.
    J Exp Med. 1979 Oct 1;150(4):938-49 PMID: 92521
  13. Macrophage oxygen-dependent antimicrobial activity. II. The role of oxygen intermediates.
    J Exp Med. 1979 Oct 1;150(4):950-64 PMID: 512587
  14. Failure to trigger the oxidative metabolic burst by normal macrophages: possible mechanism for survival of intracellular pathogens.
    J Exp Med. 1980 Feb 1;151(2):328-46 PMID: 7356726
  15. Intracellular levels and stimulated release of lysosomal enzymes from human peripheral blood monocytes and monocyte-derived macrophages.
    J Reticuloendothel Soc. 1980 Sep;28(3):249-64 PMID: 6251217
  16. Macrophage oxygen-dependent antimicrobial activity. III. Enhanced oxidative metabolism as an expression of macrophage activation.
    J Exp Med. 1980 Dec 1;152(6):1596-609 PMID: 6256463
  17. Macrophage oxygen-dependent antimicrobial activity. IV. Role of endogenous scavengers of oxygen intermediates.
    J Exp Med. 1980 Dec 1;152(6):1610-24 PMID: 7452149
  18. Interactions between murine macrophages and obligate intracellular protozoa.
    Am J Pathol. 1981 Jan;102(1):127-32 PMID: 7468756
  19. Interaction of Leishmania donovani promastigotes with human monocyte-derived macrophages: parasite entry, intracellular survival, and multiplication.
    Infect Immun. 1981 Jun;32(3):1249-53 PMID: 7251165
  20. Susceptibility of Leishmania to oxygen intermediates and killing by normal macrophages.
    J Exp Med. 1981 May 1;153(5):1302-15 PMID: 7252418
  21. Interaction of Leishmania with a macrophage cell line. Correlation between intracellular killing and the generation of oxygen intermediates.
    J Exp Med. 1981 Jun 1;153(6):1690-5 PMID: 7252424
  22. Cell-mediated immunity in American visceral leishmaniasis: reversible immunosuppression during acute infection.
    Infect Immun. 1981 Aug;33(2):498-500 PMID: 7275314
  23. Phagocytosis and killing of the protozoan Leishmania donovani by human polymorphonuclear leukocytes.
    J Immunol. 1981 Oct;127(4):1438-43 PMID: 7276565
  24. Elimination of Leishmania donovani amastigotes by activated macrophages.
    Infect Immun. 1981 Sep;33(3):918-26 PMID: 7287190
  25. Hydrogen peroxide metabolism in human monocytes during differentiation in vitro.
    J Clin Invest. 1981 Nov;68(5):1243-52 PMID: 6271809
  26. Experimental cutaneous leishmaniasis. I. Nonspecific immunodepression in BALB/c mice infected with Leishmania tropica.
    J Immunol. 1981 Dec;127(6):2395-400 PMID: 6457874
  27. Activated human monocytes inhibit the intracellular multiplication of Legionnaires' disease bacteria.
    J Exp Med. 1981 Nov 1;154(5):1618-35 PMID: 7299350
  28. Cultured human monocytes require exposure to bacterial products to maintain an optimal oxygen radical response.
    J Immunol. 1982 Jan;128(1):123-8 PMID: 6274954
  29. Formation of multinucleated giant cells from human monocyte precursors. Mediation by a soluble protein from antigen-and mitogen-stimulated lymphocytes.
    J Exp Med. 1982 Jan 1;155(1):168-78 PMID: 7054356
  30. Specific inhibition of lymphocyte-proliferation responses by adherent suppressor cells in diffuse cutaneous leishmaniasis.
    N Engl J Med. 1982 Feb 18;306(7):387-92 PMID: 6460184
  31. Trypanosoma cruzi: induction of microbicidal activity in human mononuclear phagocytes.
    J Immunol. 1982 May;128(5):2142-6 PMID: 6801131
  32. Role for endogenous and acquired peroxidase in the toxoplasmacidal activity of murine and human mononuclear phagocytes.
    J Clin Invest. 1982 May;69(5):1099-111 PMID: 7068848
  33. Cell-mediated immune response in experimental visceral leishmaniasis. I. Correlation between resistance to Leishmania donovani and lymphokine-generating capacity.
    J Immunol. 1982 Jul;129(1):344-50 PMID: 7086136
  34. Cell-mediated immune response in experimental visceral leishmaniasis. II. Oxygen-dependent killing of intracellular Leishmania donovani amastigotes.
    J Immunol. 1982 Jul;129(1):351-7 PMID: 6282967
  35. A role for oxygen-dependent mechanisms in killing of Leishmania donovani tissue forms by activated macrophages.
    J Immunol. 1982 Aug;129(2):850-5 PMID: 6282971
  36. Failure of the phagocytic oxidative response to protect human monocyte-derived macrophages from infection by Leishmania donovani.
    J Immunol. 1982 Sep;129(3):1282-6 PMID: 7108206
  37. Lymphokines enhance the capacity of human monocytes to secret reactive oxygen intermediates.
    J Clin Invest. 1982 Nov;70(5):1042-8 PMID: 7130393
  38. Suppression of macrophage oxidative metabolism by products of malignant and nonmalignant cells.
    J Exp Med. 1982 Oct 1;156(4):945-61 PMID: 7153714
  39. Protein measurement with the Folin phenol reagent.
    J Biol Chem. 1951 Nov;193(1):265-75 PMID: 14907713
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1983-07-00
Pages
32-44
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC1129158
Subset
IM
Grants
NIAID NIH HHS · AI 16963 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com